Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Avanir Pharmaceuticals patents

List of Avanir Pharmaceuticals patents

List of MeadWestvaco patents

List of Birchwood Laboratories patents

List of Bandai Namco Entertainment patents

List of manufacturing products

List of companies in Next Wave Impact's investment portfolio

Patents where

Current Assignee

Name

is

Avanir Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7365200 Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors	Patent 7365200 was granted and assigned to Avanir Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.		Avanir Pharmaceuticals		United States Patent and Trademark Office	7365200	April 29, 2008
	‌ US Patent 7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases	Patent 7361760 was granted and assigned to Avanir Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.		Avanir Pharmaceuticals		United States Patent and Trademark Office	7361760	April 22, 2008
	‌ US Patent 8227484 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders	Patent 8227484 was granted and assigned to Avanir Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.		Avanir Pharmaceuticals		United States Patent and Trademark Office	8227484	July 24, 2012
	‌ US Patent 7659282 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders	Patent 7659282 was granted and assigned to Avanir Pharmaceuticals on February, 2010 by the United States Patent and Trademark Office.		Avanir Pharmaceuticals		United States Patent and Trademark Office	7659282	February 9, 2010
	‌ US Patent 7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same	Patent 7432374 was granted and assigned to Avanir Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.		Avanir Pharmaceuticals		United States Patent and Trademark Office	7432374	October 7, 2008
	‌ US Patent 7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same	Patent 7312220 was granted and assigned to Avanir Pharmaceuticals on December, 2007 by the United States Patent and Trademark Office.		Avanir Pharmaceuticals		United States Patent and Trademark Office	7312220	December 25, 2007
	‌ US Patent 7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor	Patent 7732146 was granted and assigned to Avanir Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.		Avanir Pharmaceuticals		United States Patent and Trademark Office	7732146	June 8, 2010
	‌ US Patent 10730841 Methods for the synthesis of deuterated dextromethorphan		Avanir Pharmaceuticals	Avanir Pharmaceuticals		United States Patent and Trademark Office	10730841	August 4, 2020
	‌ US Patent 10865187 Methods for the synthesis of deuterated dextromethorphan		Avanir Pharmaceuticals	Avanir Pharmaceuticals		United States Patent and Trademark Office	10865187	December 15, 2020

9 results

0 selected

9 results

0 selected